The FDA's decision to need more trials delays potential approval of MDMA as a PTSD treatment, leaving patients and advocates are also disappointed. ...
Civil health experts weigh implicit blessing of MDMA for PTSD treatment amid enterprises over safety and cerebral goods, while lawyers punctuate its remedial implicit ...